Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

2(33%)

Results Posted

0%(0 trials)

Terminated

1(17%)

Phase Distribution

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Recruiting2

Not yet recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed233%

not_yet_recruiting117%

recruiting233%

terminated117%

Recent Activity

2 active trials

Showing 5 of 6

not_yet_recruiting

The Role of Inflammatory Markers in OSAHS-Related White Matter Lesions and Asymptomatic Lacunar Infarction

NCT07061990

completed

Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)

NCT03718494

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT07226466

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

Not Yet Recruiting

NCT06399952

Baker Gordon Syndrome Natural History Study

Recruiting

NCT04250493Not Applicable

Insulin Resistance in Multiple System Atrophy

Recruiting

NCT07061990

The Role of Inflammatory Markers in OSAHS-Related White Matter Lesions and Asymptomatic Lacunar Infarction

Completed

NCT03718494

Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)

Completed

NCT03342612Not Applicable

Multimodal Neuroimaging Analysis After Mild Traumatic Brain Injury

Terminated

All 6 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 6